Yuval Cabilly

Yuval has served as a member of the Board of Directors since 2021. He is the co-founder and Managing Partner of Israel Biotech Fund, a venture capital fund investing in exceptional Israeli pharmaceutical companies. Yuval serves on the Board of Directors of Pharma Two B and Tamarix. He is also the co-founder and a Board Member of 8400 – The Health Network. Dr. Cabilly received his PhD in molecular cell biology from the Tel Aviv University. His research focused on neurodegenerative diseases.